-
摘要: 高级别浆液性癌(high-grade serous carcinoma，HGSC)是卵巢癌最常见的组织学类型，腹膜后HGSC是非常罕见的病例，其发病机制仍不清楚。本文通过报道1例腹膜后HGSC患者的治疗过程，增加医师对腹膜后HGSC临床病理特点的了解，从而为患者选择更优更合适的治疗方案。Abstract: High-grade serous carcinoma (HGSC) is the most common histological type of ovarian cancer. Retroperitoneal HGSC is very rare and its pathogenesis remains unclear. In this paper, we reported the treatment process of a patient with retroperitoneal HGSC so as to increase doctors' understanding of its clinicopathological characteristics and select a better and more appropriate treatment plan for the patient.
-
-
[1] Gemici K, Buldu, Acar T, et al. Management of patients with retroperitoneal tumors and a review of the literature[J]. World J Surg Oncol, 2015, 13: 143. doi: 10.1186/s12957-015-0548-z
[2] Mansour S, Azzam N, Kluger Y, et al. Retroperitoneal liposarcoma: the giant type[J]. J Med Cases, 2022, 13(10): 517-520. doi: 10.14740/jmc4014
[3] Berek JS, Renz M, Kehoe S, et al. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update[J]. Int J Gynaecol Obstet, 2021, 155(Suppl 1): 61-85. http://doc.paperpass.com/foreign/rgArti2021213488211.html
[4] Komiyama S, Nishijima Y, Kondo H, et al. Multicenter clinicopathological study of high-grade serous carcinoma presenting as primary peritoneal carcinoma[J]. Int J Gynecol Cancer, 2018, 28(4): 657-665. doi: 10.1097/IGC.0000000000001167
[5] Iura A, Sasajima Y, Katsumata N, et al. Serous adenocarcinoma of the retroperitoneum, as a type of multifocal müllerian carcinoma[J]. Int J Clin Oncol, 2009, 14(3): 254-257. doi: 10.1007/s10147-008-0827-6
[6] McDaniel AS, Stall JN, Hovelson DH, et al. Next-generation sequencing of tubal intraepithelial carcinomas[J]. JAMA Oncol, 2015, 1(8): 1128-1132. doi: 10.1001/jamaoncol.2015.1618
[7] Schneider S, Heikaus S, Harter P, et al. Serous tubal intraepithelial carcinoma associated with extraovarian metastases[J]. Int J Gynecol Cancer, 2017, 27(3): 444-451. doi: 10.1097/IGC.0000000000000920
[8] Suda K, Nakaoka H, Hata C, et al. Concurrent isolated retroperitoneal HGSC and STIC defined by somatic mutation analysis: a case report[J]. Diagn Pathol, 2019, 14(1): 17. doi: 10.1186/s13000-019-0795-3
[9] Soong TR, Howitt BE, Horowitz N, et al. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma[J]. Gynecol Oncol, 2019, 152(2): 426-433. doi: 10.1016/j.ygyno.2018.11.033
[10] Böhm S, Faruqi A, Said I, et al. Chemotherapy response score: development and validation of a system to quantify histopathologic response to neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma[J]. J Clin Oncol, 2015, 33(22): 2457-2463. doi: 10.1200/JCO.2014.60.5212
[11] Ikeda Y, Yoshihara M, Tamauchi S, et al. Survival benefits of retroperitoneal lymphadenectomy for optimally-resected advanced ovarian high-grade serous carcinoma: a multi-institutional retrospective study[J]. J Gynecol Oncol, 2022, 33(4): e40. doi: 10.3802/jgo.2022.33.e40
[12] McEachron J, Marshall L, Zhou N, et al. Evaluation of survival, recurrence patterns and adjuvant therapy in surgically staged high-grade endometrial cancer with retroperitoneal metastases[J]. Cancers(Basel), 2021, 13(9): 2052. http://pubmed.ncbi.nlm.nih.gov/33922792/
[13] Banerjee S, Moore KN, Colombo N, et al. Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation(SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Oncol, 2021, 22(12): 1721-1731. doi: 10.1016/S1470-2045(21)00531-3
[14] 杨菁, 杜娟, 王玉湘, 等. JAK/STAT信号通路在卵巢高级别浆液性癌中的激活及预后意义[J]. 北京大学学报(医学版), 2023, 55(2): 270-275.
-
下载:
计量
- 文章访问数: 59
- 施引文献: 0